Company: INMB
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003354
Chunk: 29

Company: Inmune Bio, Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1
Chunk 29
---
Pending Applications  
    # Issued Patents  
    Geographical Scope  
    Nominal Patent Term 
  
    INB-16 / INKmune compositions 
     5  
     0  
     global  
     2043 
  
    Use of INKmune for treating disease 
     4  
     5  
     global  
     2036-2043 

17

CORDStrom (MSCs)

CORDstrom is a cell suspension
for intravenous infusion or injection comprising aseptic, allogeneic, pooled HucMSCs. CORDStrom solves certain manufacturing and CMC limitations
known to affect mesenchymal stem/stromal cell products, namely, improved batch-to-batch consistency and scalable manufacturing. We have
filed patent applications directed to CORDStrom including claims covering composition of matter, formulation, and methods of treating
various disease indications. In addition, we protect manufacturing trade secrets with a series of confidentiality provisions in various
agreements. The following table summarizes current IP covering our CORDStrom platform technology:

    Subject Matter / Compound 
    # Pending Applications  
    # Issued Patents  
    Geographical Scope  
    Nominal Patent Term 
  
    CORDStrom compositions and formulations 
     1  
     0  
     global  
     2045 
  
    Use of CORDStrom for treating disease 
     1  
     0  
     global  
     2045 

General IP Disclosures 

Our commercial success depends
in part on obtaining and maintaining patent and trade secret protections, where applicable, of our current and future product candidates
and the methods used to manufacture them, as well as successfully defending our patents against third-party challenges.

Our ability to stop third
parties from making, using, selling, offering to sell or importing our products depends on the extent to which we have rights under valid
and enforceable patents or trade secrets that cover these activities, and whether we are able to enforce such rights. We cannot assure
you that our pending patent applications will result in issued patents, or that any or all rights will be enforceable in every jurisdiction
whether or not patent rights are sought.

International PCT patent applications
cover all 152 nations which are signatories of the PCT. However,